A prostate cancer study showed that depletion of ELOVL5 altered mitochondrial morphology and function, leading to reactive oxygen species production, and that supplementation of ELOVL5 direct products reversed oxidative stress [74]. Here, ELOVL5 is linked to prostate carcinoma.